FEDERATED HERMES, INC. - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 171 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$347,678
+17283.9%
80,481
+26115.3%
0.00%
Q3 2022$2,000
-99.8%
307
-99.8%
0.00%
-100.0%
Q2 2022$1,284,000
-4.3%
127,797
+18.0%
0.00%0.0%
Q1 2022$1,341,000
+120.6%
108,301
+307.4%
0.00%
+200.0%
Q4 2021$608,000
-62.8%
26,585
-64.0%
0.00%
-66.7%
Q3 2021$1,634,000
-21.0%
73,816
-53.7%
0.00%
-25.0%
Q2 2021$2,068,000
+23.2%
159,526
+23.5%
0.00%
+33.3%
Q1 2021$1,678,000
+6.3%
129,208
+13.3%
0.00%0.0%
Q4 2020$1,578,000
+1.1%
114,032
+7.6%
0.00%
-25.0%
Q3 2020$1,561,000106,0170.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders